Inhibitor of differentiation 1 (ID1), which has a helix-loop-helix structure that forms heterodimers with transcription factors, thereby inhibiting their function, has been shown to be highly expressed in GBM and identified as a key factor for maintaining features of glioma stem cells (GSCs) [15]. This evidence concerns the gene ID1 and central nervous system cancer.